Cargando…
Case report: A case of classic hairy cell leukemia with CNS involvement treated with vemurafenib
Hairy cell leukemia (HCL) is a rare mature B-cell lymphoproliferative disorder and most often presents as classic hairy cell leukemia. This entity is characterized by an indolent course and the presence of the BRAF V600E mutation. We report the case of an 80-year-old man with a history of classical...
Autores principales: | Johnson, Anna E., Raju, Athul Raj, Jacob, Aasems, Hildebrandt, Gerhard C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877286/ https://www.ncbi.nlm.nih.gov/pubmed/36713531 http://dx.doi.org/10.3389/fonc.2022.1100577 |
Ejemplares similares
-
Targeting MEK in vemurafenib-resistant hairy cell leukemia
por: Caeser, Rebecca, et al.
Publicado: (2018) -
Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox
por: Robak, Tadeusz, et al.
Publicado: (2021) -
Low‐dose vemurafenib in hairy cell leukemia patients with active infection
por: Bohn, Jan‐Paul, et al.
Publicado: (2019) -
Synchronous or Metachronous Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: A Case Series and Literature Review
por: Verma, Vivek, et al.
Publicado: (2017) -
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
por: Schlaweck, Sebastian, et al.
Publicado: (2021)